HIGHLIGHTS
- who: Caixia Li from the Fudan University, China have published the article: Case report: Olaparib as an experimental therapy in a BRCA2-mutated patient with metastatic ovarian adenocarcinoma that originated from liver cancer, in the Journal: (JOURNAL) of 18/08/2020
- what: The authors report the case of a 66-year-old woman with rare ovarian and omentum metastases that originated from liver cancer.
- how: In the case of the patient the authors prepared genetic test with the patient`s consent after the operation and the results showed that the patient carried mutations . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.